BIO
Biome Australia Limited
π¦πΊ ASX
ποΈ CONSUMER
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 80.88%
Annual Growth
3 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
18
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. The firm develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. The company develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema through randomized double-blind placebo-controlled trials. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, and Biome Acne Probiotic.
π Performance
Price History
+237.50%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.68
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in BIO
19
π Total Capital Earnings
$20K
π Average investment frequency
27 weeks
π΅ Average investment amount
$1,529
β° Last time a customer invested in BIO
21 hours
BIO investor breakdown
π΅ Income of investors
More than 200k
10%
150k - 200k
100k - 150k
10%
50k - 100k
38%
Less than 50k
38%
πΆ Age of investors
18 - 25
16%
26 - 34
21%
35 - 90
63%
π Legal gender of investors
Female
42%
Male
58%
Pearlers who invest in BIO also invest in...
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
12.86%
π Share price
$129.54 AUD
π GLOBAL
β³οΈ DIVERSIFIED
π€ TECHNOLOGY
π HIGH PRICE GROWTH
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
3.85%
π Share price
$100.90 AUD
β³οΈ DIVERSIFIED
π¦πΊ AUSTRALIA
𧱠MATERIALS
πΈ FINANCIALS
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
π Performance (5Yr p.a)
18.86%
π Share price
$57.74 AUD
π HIGH PRICE GROWTH
πΊπΈ UNITED STATES
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6138.42m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
π Performance (5Yr p.a)
4.31%
π Share price
$135.91 AUD
β³οΈ DIVERSIFIED
πΈ FINANCIALS
Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 48,930 full-time employees. The company serves approximately 17 million customers. The firm's segments include Retail Banking Services, Business Banking, Institutional Banking and Markets and New Zealand. Retail Banking Services segment provides banking products and services to personal customers, and banking and advisory services for high-net-worth individuals. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial service solutions. Institutional Banking and Markets offers a full range of financial services solutions including access to debt capital markets, transaction banking, working capital and risk management. New Zealand includes the banking and funds management businesses operating in New Zealand under the ASB brand.
π Performance (5Yr p.a)
17.34%
π Share price
$143.85 AUD
π¦ BANKING
βοΈ HIGH GOVERNANCE
π HIGH ESG SCORE
π³ ENVIRONMENTAL
π HIGH PRICE GROWTH
Want more shares? Try these...
Bisalloy Steel Group Ltd. engages in the production and sale of bisalloy quenched and tempered steel plate. The company is headquartered in Wollongong, New South Wales. The company went IPO on 2003-06-23. The Companyβs products are used in the mining, construction, general fabrication and defense sectors. The firm operates through two geographic segments: Australia and Overseas. The Australian operations comprise of Bisalloy Steels Pty Limited and Bisalloy Steel Group Limited. Bisalloy Steels Pty Limited manufactures and sells wear-grade and high tensile plate through distributors and directly to original equipment manufacturers in both Australia and Overseas. The Overseas operations comprise of PT Bima Bisalloy and Bisalloy (Thailand) Co Limited located in Indonesia and Thailand respectively. These businesses distribute Bisalloy Q&T plate as well as other plate products. The company has a distribution network across Australasia, Indonesia, Thailand, the Peopleβs Republic of China and the United Arab Emirates.
π Performance (5Yr p.a)
34.14%
π Share price
$3.14 AUD
π HIGH PRICE GROWTH
βοΈ MINING
π° HIGH DIVIDEND
Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. The company is headquartered in North Ryde, New South Wales. The company went IPO on 2001-01-24. The firm is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Companyβs clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.
π Performance (5Yr p.a)
-14.48%
π Share price
$0.02 AUD
𧬠BIOTECHNOLOGY
BILL.AX was created on 2017-06-02 by iShares. The fund's investment portfolio concentrates primarily on broad credit fixed income. The Fund aims to provide investors with the performance, before fees and expenses, of an index comprised of Australian bank bills.
π Performance (5Yr p.a)
0.09%
π Share price
$100.71 AUD
πΊπΈ EX UNITED STATES
Bindi Metals Ltd. is an exploration company, which engages in the acquisition, exploration and development of mineral exploration assets. The company is headquartered in Perth, Western Australia. The company went IPO on 2022-06-28. The firm's projects include The Biloela Project, Flanagan's Project and Great Blackall Project. The Biloela Project comprises one granted Exploration Permit for Minerals (EPM) 27428, which covers a total area of 20 sub-blocks for an area of approximately 62 square kilometers (km). The Biloela Project is located approximately 30 km southeast of Biloela, 93 km southwest of the Port of Gladstone and 390 km north-northwest of Brisbane. The prospects on the Biloela Tenement are: Flanagans, Great Blackall, Inverted Pig Prospect, and Quartz Ridge. Its Flanagan's Project is 1.5 kilometer long by 180-meter wide outcropping gold rich mineralized zone hosted by diorite. The firm's Great Blackall Project covers over 500 meter of outcropping high-grade copper - gold mineralization with numerous historical shafts. The Inverted Pig prospect occurs immediately south of the Great Blackall Copper prospect.
π Share price
$0.09 AUD
βοΈ MINING